Of mice and men (and women) and the acylation-stimulating protein pathway

被引:42
作者
Sniderman, AD [1 ]
Maslowska, M [1 ]
Cianflone, K [1 ]
机构
[1] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Mike Rosenbloom Lab Cardiovasc Res, Montreal, PQ H3A 1A1, Canada
关键词
D O I
10.1097/00041433-200006000-00010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The storage and release of energy by adipocytes is of fundamental biologic importance. Not surprisingly, therefore, the rate at which these processes occur can be modulated by a variety of physiologic molecules. A newly recognized participant is produced by adipocytes themselves: acylation-stimulating protein (ASP), This article focuses on the most recent in-vivo evidence regarding how the ASP pathway may influence energy storage and release. In brief, the rate at which triglycerides are cleared from plasma (i.e. the rate at which they are hydrolysed) is determined by lipoprotein lipase and insulin, which is the principal hormone that regulates lipoprotein lipase, By contrast, the ASP pathway modulates the rate at which fatty acids are taken up and converted to triglycerides by adipocytes. Under certain circumstances, however, reduction of activity of the ASP pathway may negatively impact on the first step of the process. ASP also influences the rate at which fatty acids are released by adipocytes, and it is clear that insulin and ASP interact in a variety of ways that involve energy storage and release. Accordingly, to understand the impact of any intervention on energy storage and release by adipocytes, the effects of both insulin and ASP must be taken into account. Curr Opin Lipidol 11:291-296. (C) 2000 Lippincott Wiliiams & Wilkins.
引用
收藏
页码:291 / 296
页数:6
相关论文
共 19 条
[11]   Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein [J].
Murray, I ;
Havel, PJ ;
Sniderman, AD ;
Cianflone, K .
ENDOCRINOLOGY, 2000, 141 (03) :1041-1049
[12]   Molecular pathobiology of the human lipoprotein lipase gene [J].
Murthy, V ;
Julien, P ;
Gagne, C .
PHARMACOLOGY & THERAPEUTICS, 1996, 70 (02) :101-135
[13]   TRIGLYCERIDE LIPASES AND ATHEROSCLEROSIS [J].
OLIVECRONA, G ;
OLIVECRONA, T .
CURRENT OPINION IN LIPIDOLOGY, 1995, 6 (05) :291-305
[14]  
Saleh J, 1998, J LIPID RES, V39, P884
[15]   Chylomicron-specific enhancement of acylation stimulating protein and precursor protein C3 production in differentiated human adipocytes [J].
Scantlebury, T ;
Maslowska, M ;
Cianflone, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (33) :20903-20909
[16]   The adipocyte, fatty acid trapping, and atherogenesis [J].
Sniderman, AD ;
Cianflone, K ;
Amer, P ;
Summers, LKM ;
Frayn, KN .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (02) :147-151
[17]   Mechanisms involved in the regulation of free fatty acid release from isolated human fat cells by acylation-stimulating protein and insulin [J].
Van Hermelen, V ;
Reynisdottir, S ;
Cianflone, K ;
Degerman, E ;
Hoffstedt, J ;
Nilsell, K ;
Sniderman, A ;
Arner, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (26) :18243-18251
[18]   Genetic deficiency of acylation stimulating protein (ASP(C3ades-Arg)) does not cause hyperapobetalipoproteinemia in mice [J].
Wetsel, RA ;
Kildsgaard, J ;
Zsigmond, E ;
Liao, W ;
Chan, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (27) :19429-19433
[19]  
Zhang XJ, 1998, EUR J CLIN INVEST, V28, P730